peptides

  • Chimpanzee Adenovirus Y25 (Penton Protein)

    Chimpanzee Adenovirus Y25 (Penton Protein)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Cancer, Gene therapy, Infection Layout: Freeze-dried in glass vial Organism: Chimpanzee Adenovirus (ChAd) Protein Name: Penton protein Purity: Research Plus Grade: each peptide is…

  • Chlamydia trachomatis (CPAF)

    Chlamydia trachomatis (CPAF)

    Amount: 25 ??g (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools Condition / Topic: Epithelium, Genital malignancies, Infection Layout: Freeze-dried in glass vial Organism: Chlamydia trachomatis Protein Name: Protein Purity: Development Grade: each peptide purified to > 70% (HPLC/MS) Quantification: No Sequence:…

  • Chlamydia trachomatis (DEGPL)

    Chlamydia trachomatis (DEGPL)

    Amount: 25 ??g (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools Condition / Topic: Epithelium, Genital malignancies, Infection Layout: Freeze-dried in glass vial Organism: Chlamydia trachomatis Protein Name: Protein Purity: Development Grade: each peptide purified to > 70% (HPLC/MS) Quantification: No Sequence:…

  • Chlamydia trachomatis (MOMP)

    Chlamydia trachomatis (MOMP)

    Amount: 25 ??g (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools Condition / Topic: Epithelium, Genital malignancies, Infection Layout: Freeze-dried in glass vial Organism: Chlamydia trachomatis Protein Name: Outer membrane protein Purity: Development Grade: each peptide purified to > 70% (HPLC/MS) Quantification:…

  • Clinical Proteomics Peptides SpikeTides?_TQL PLUS

    Clinical Proteomics Peptides SpikeTides?_TQL PLUS

  • Clostridium tetani (strain Massachusetts / E88) Tetanus toxin 830-844, QYIKANSKFIGITEL

    Clostridium tetani (strain Massachusetts / E88) Tetanus toxin 830-844, QYIKANSKFIGITEL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Autoimmune disease, Multiple sclerosis Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Clostridium tetani Protein Name: Tetanus Toxin Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-QYIKANSKFIGITEL-OH Specifications: 15mer peptide as TFA salt

  • Clostridium tetani E88 Tetanus toxin  836-851, AQYIKANSKFIGITEL

    Clostridium tetani E88 Tetanus toxin 836-851, AQYIKANSKFIGITEL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Cancer Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Clostridium tetani Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-AQYIKANSKFIGITEL-OH WT Sequence: SKFIGITELKKLESKI Specifications: 16mer peptide as TFA salt

  • CMV pp65 (113-121) - HLA-A*24:02 (VYALPLKML)

    CMV pp65 (113-121) – HLA-A*24:02 (VYALPLKML)

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Control, Cytomegalovirus disease, Infectious mononucleosis, Opportunistic infections Layout: Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: 65 kDa phosphoprotein (pp65) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-VYALPLKML-OH Specifications: 9mer peptide as TFA salt

  • CMV pp65 (123-131) - HLA-B*35:01 (IPSINVHHY)

    CMV pp65 (123-131) – HLA-B*35:01 (IPSINVHHY)

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Control, Cytomegalovirus disease, Infectious mononucleosis, Opportunistic infections Layout: Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: 65 kDa phosphoprotein (pp65) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-IPSINVHHY-OH Specifications: 9mer peptide as TFA salt

  • CMV pp65 (16-24) - HLA-A*11:01 (GPISGHVLK)

    CMV pp65 (16-24) – HLA-A*11:01 (GPISGHVLK)

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Control, Cytomegalovirus disease, Infectious mononucleosis, Opportunistic infections Layout: Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: 65 kDa phosphoprotein (pp65) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-GPISGHVLK-OH Specifications: 9mer peptide as TFA salt

  • CMV pp65 (188-195) - HLA-B*35:08 (FPTKDVAL)

    CMV pp65 (188-195) – HLA-B*35:08 (FPTKDVAL)

    Category: Antigen Peptides Layout: Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: 65 kDa phosphoprotein (pp65) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-FPTKDVAL-OH Specifications: peptide as TFA salt

  • CMV pp65 (211-219) - HLA-C*06:02 (TRATKMQVI)

    CMV pp65 (211-219) – HLA-C*06:02 (TRATKMQVI)

    Category: Antigen Peptides Layout: Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: 65 kDa phosphoprotein (pp65) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-TRATKMQVI-OH

  • CMV pp65 (265-275) - HLA-B*07:02 (RPHERNGFTVL)

    CMV pp65 (265-275) – HLA-B*07:02 (RPHERNGFTVL)

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Control, Cytomegalovirus disease, Infectious mononucleosis, Opportunistic infections Layout: Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: 65 kDa phosphoprotein (pp65) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-RPHERNGFTVL-OH Specifications: 11mer peptide as TFA salt

  • CMV pp65 (267-275) - HLA-B*40:01 (HERNGFTVL)

    CMV pp65 (267-275) – HLA-B*40:01 (HERNGFTVL)

    Category: Antigen Peptides Layout: Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: 65 kDa phosphoprotein (pp65) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-HERNGFTVL-OH

  • CMV pp65 (340-348) - HLA-B*15:01 (RQYDPVAAL)

    CMV pp65 (340-348) – HLA-B*15:01 (RQYDPVAAL)

    Category: Antigen Peptides Layout: Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: 65 kDa phosphoprotein (pp65) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-RQYDPVAAL-OH Specifications: 9mer peptide as TFA salt

  • CMV pp65 (340-355) - HLA-A*24:02 (RQYDPVAALFFFDIDL)

    CMV pp65 (340-355) – HLA-A*24:02 (RQYDPVAALFFFDIDL)

    Category: Antigen Peptides Layout: Freeze-dried in plastic vial Organism: Human Cytomegalovirus (HCMV) Protein Name: 65 kDa phosphoprotein (pp65) Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-RQYDPVAALFFFDIDL-OH Specifications: peptide as TFA salt